9/11/2012 10:15:30 AM
WILMINGTON, N.C.--(BUSINESS WIRE)--Osmotica Pharmaceutical Corp. today announced the execution of a strategic alliance agreement between Panacea Biotec and Osmotica Kft. for the research, development and commercialization of brand and generic products in the United States and key strategic markets across the globe. Under the terms of the agreement, Panacea Biotec will lead product development and manufacturing while Osmotica will lead product registration and legal matters, as well as commercialization. The collaboration products are expected to be sold under an Osmotica and Panacea Biotec label. This collaboration is based on equal sharing of risk, investment and profits by the companies. A large and therapeutically diverse portfolio of products are progressing at various stages of development, with additional products under consideration.
comments powered by